MFDS
- Status: likely_approved
🇰🇷 Alhemo in South Korea
Alhemo (CONCIZUMAB) regulatory status in South Korea.
Marketing authorisation
Alhemo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in South Korea
Frequently asked questions
Is Alhemo approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Alhemo in South Korea?
Novo Nordisk Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.